₨ 45,000
Keytruda (pembrolizumab) is an immunotherapy drug used to treat many types of cancer. It works by helping your body's immune system detect and attack cancer cells more effectively.
Key Information
- Active Ingredient: The active substance is pembrolizumab.
- Mechanism: It is an immune checkpoint inhibitor that targets the PD-1 pathway, effectively removing a "brake" on the immune system and allowing T-cells to attack cancer cells that would otherwise hide.
- Administration: The medication is a concentrate for intravenous infusion and must be administered by a healthcare professional in a hospital or clinic setting.
- Uses: Keytruda is approved to treat numerous cancers, including:
- Melanoma (skin cancer)
- Non-small cell lung cancer (NSCLC)
- Head and neck squamous cell carcinoma (HNSCC)
- Classical Hodgkin lymphoma
- Urothelial (bladder and urinary tract) cancer
- Triple-negative breast cancer
- Renal cell carcinoma (kidney cancer)
- Colorectal, gastric, esophageal, cervical, and biliary tract cancers with specific biomarkers
- Side Effects: Common side effects include fatigue, nausea, diarrhea, rash, and muscle pain. Serious immune-mediated side effects, such as inflammation of the lungs, liver, or colon, can occur.
Disclaimer: This information is for informational purposes only, and does not constitute medical advice. Please consult a healthcare professional for any health concerns or before starting any new treatment.
₨ 10,000
